Konnie Knox and Donald Carrigan on HHV-6 and AIDS

"The epidemic of the acquired immunodeficiency
syndrome (AIDS) is in its second decade and continues
its worldwide expansion. In some developing countries,
more than 20% of all adults are infected with the
human immunodeficiency virus (HIV).1 The successful
use of multiple antiviral drug therapies has been
limited by the complex dosing schedules required and
by the emergence of resistant forms of HIV. Work on
vaccines to prevent or treat HIV infections continues,
but it appears that an effective vaccine is still
several years away. Clearly, there exists a need for
new strategies in the treatment of HIV disease,
especially if these strategies can provide new targets
for effective pharmaceutical or immunological
therapies. Human herpesvirus six (HHV-6) may serve as
an important cofactor in the pathogenesis of AIDS and
may provide an alternative target for therapeutic
intervention."
http://www.wisconsinlab.com/hiv.htm